* Outset Medical Inc OM.OQ OM.O is expected to show a
rise in
quarterly revenue when it reports results on February 16.
* The San Jose California-based company is expected to
report a
53.2% increase in revenue to $26.425 million from $17.25 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Outset Medical Inc
is for
a loss of 77 cents per share. For the same quarter last year,
the company reported a loss of 75 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Outset
Medical
Inc is $61, about 41.2% above its last closing price
of $35.87.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.77 -0.73 -0.65 Beat 11
Jun. 30 2021 -0.69 -0.70 -0.66 Beat 5.4
Mar. 31 2021 -0.80 -0.81 -0.70 Beat 13.7
Dec. 31 2020 -0.66 -0.66 -0.75 Missed -13
Sep. -3.10 -3.10 -3.31 Missed -6.7
30 2020
This summary was machine generated February 15 at 02:43 GMT.
All figures in US dollars unless otherwise stated